Continuing Medical EducationUPDATE ON RETINOBLASTOMAABRAMSON, DAVID H. MD, FACS*; SCHEFLER, AMY C. MD†Author Information *Chief, Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY. †Resident in Ophthalmology, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL The authors have disclosed no significant relationships with or financial interests in any commercial companies that pertains to this educational activity. Reprint requests: David H. Abramson, MD, 70 E. 66 St., NY, NY 10021; e-mail: [email protected] Retina: December 2004 - Volume 24 - Issue 6 - p 828-848 Buy CME Test In Brief As in the majority of ophthalmic subspecialties, standard diagnostic and treatment strategies within ophthalmic oncology change frequently as new studies elucidate the success or failure of previous approaches to patient care. Methods of diagnosis, treatment, and prevention of retinoblastoma change even more frequently than for any other benign or malignant intraocular lesion managed by ophthalmic oncologists. © The Ophthalmic Communications Society, Inc.